Unlock this StockReport nowClick to Unlock

Corteva Inc Share Price

CTVA $30.29 -0.3  -0.9%
9:10pm
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 30th Jul, paid: 13th Sep more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $

FINANCIAL BRIEF: For the six months ended 30 June 2019, Corteva Inc revenues decreased 6% to $8.95B. Net income before extraordinary items totaled $273M vs. loss of $87M. Revenues reflect Seed-Corn segment decrease of 40% to $2.25B, Crop Protection-Herbicides segment decrease of 41% to $1.07B. Net Income reflects Research and development expense decrease of 17% to $568M (expense), Restructuring Charges/Provisions decrease of 48% to $121M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
D-
D-
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Jun '19) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: $33.0
(+7.81% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +5.1% ($) ($) ($) ($) ($) ($)
Consensus Estimate
1m Change
3m Change
23 brokers Broker Consensus Trend
Broker Recommendations for Corteva Inc
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 1 0 12 7 2

Named Brokers and Analysts
Bank of America Merrill Lynch , Deutsche Bank David Begleiter , Jefferies , Credit Suisse - North America , RBC Capital Markets Arun Viswanathan , Stephens Inc. Mark Connelly , Morgan Stanley , Citi , BMO Capital Markets Joel Jackson , SunTrust Robinson Humphrey Capital Markets James Sheehan , BERNSTEIN Jonas Oxgaard , Goldman Sachs Research Adam Samuelson , Argus Research Corporation , Loop Capital Christopher Kapsch , UBS Equities , Susquehanna Financial Group LLLP Donald Carson , Macquarie Research Cooley May , JPMorgan Jeffrey Zekauskas , Barclays Duffy Fischer , Monness, Crespi, Hardt, & Co Inc. Christopher Shaw , Morningstar, Inc. Seth Goldstein , Nomura | Instinet Aleksey Yefremov , Fermium Research Frank Mitsch ,

Profile Summary

Corteva, Inc. is a provider of agricultural products. The Company’s seed platform develops and supplies germplasm. Its crop protection platform supplies products to protect crop yields against weeds, insects and disease. It operates through two segments: seed and crop protection. Its seed segment provides solutions in various crops, including corn, soybean, sunflowers and wheat, and complementary crops such as alfalfa, canola, cotton, rice and sorghum, as well as silage inoculants. Its crop protection segment is focused on developing and supplying crop protection products and services. It offers a range of crop protection products that service field crops, such as wheat, corn, soybean, sunflower, canola/oilseed rape and rice as well as specialty crops such as fruit, nut, vine, sugarcane, coffee and vegetables.

No Management Information.

No. of Employees: n/a No. of Shareholders: n/a


Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated March 16, 2018
Public Since May 24, 2019
Shares in Issue 748,893,017
Free Float 747.9m (99.9%)
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange New York Stock Exchange
Eligible for an ISA? a SIPP?

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy CTVA

Access CTVA Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis